Clinical Study of Depression
About the Study
This 24-week study sponsored by Janssen Research and Development is investigating a nasal spray medication for adults battling treatment resistant depression (TRD).
If your depression hasn’t responded to two different medications, this research study could be right for you.
To be eligible to participate:
Be between the ages of 18-65
Suffer from depression
Have or have had a major depressive episode
Take or have taken two different antidepressants
To find out if you’re eligible to participate, fill out the form below
Eligible Participants Will Receive
Compensation
Potential reimbursement for your time and travel
Study Related Care
Study related medical care at no cost
Evaluations
Medical and Psychiatric evaluations
No Insurance Required
Health insurance is not required nor will it be affected
Meet the Lead Researcher
Dr. Alexander Bystritsky M.D, P.hD.
Dr. Alexander Bystritksy, M.D, Ph.D., is a California board-certified Psychiatrist with over 30 years of experience conducting clinical research in Phase II-IV sponsor-initiated trials. Dr. Bystritsky is currently the Lead Investigator on all the current research studies at CalNeuro Research Group. He’s a Distinguished Life Fellow of the American Psychiatric Association and a Life Fellow of the American Society of Clinical Psychopharmacology (ASCP). He is also a Professor Emeritus at the University of California Los Angeles (UCLA).
About CalNeuro Research
Location: Los Angeles, CA (near UCLA)
CalNeuro Research Group (CalNeuro) is an independently owned clinical research site based in Los Angeles, California. CalNeuro focuses on finding therapies and treatments of disorders of the central nervous system (CNS). The team is comprised of veterans in the mental health space and has over 60 years of combined experience conducting clinical trials in areas such as depression, anxiety, OCD, PTSD, Alzheimer’s and other neurologic/psychiatric disorders.
To find out if you’re eligible to participate, fill out the form above